TY - JOUR
T1 - Intranasal Use of Prescription Stimulants Among Adults Aged 18 to 30
T2 - Results From A Crowdsourcing Platform
AU - Vosburg, Suzanne K.
AU - Faraone, Stephen V.
AU - Riley, Elizabeth
AU - Whitaker, Timothy
AU - Kardish, Jessica
AU - Baker, David
AU - Kollins, Scott H.
AU - Rush, Craig R.
N1 - Publisher Copyright:
© ©The Author(s) 2022.
PY - 2023/1
Y1 - 2023/1
N2 - Objective: Few studies of prescription stimulant non-oral, non-medical use (NMU) (defined by use not as prescribed) have been conducted in adults beyond the college population. The purpose of this study was to characterize prescription stimulant non-oral use, specifically intranasal (IN) use (snorting) in young adults. Method: Amazon’s MTurk platform was used to recruit participants for an online survey. Data were collected from March to April 2020. Results: Thirty-two percent (n = 157) of survey respondents (N = 975), aged 18 to 30, reported IN prescription stimulant use (average of 32.1 episodes of lifetime IN use). Adderall was the most-reported prescription stimulant used intranasally (89.2%). Most IN users (82%; n = 68) reported spending no more than 5 minutes tampering with prescription stimulants. Intranasal users said they would take the medication orally if unable to tamper or manipulate medication for IN use. Conclusion: These data help quantify a complex public health issue of ongoing IN use of prescription stimulants and suggest a potential role for manipulation-deterrent medications.
AB - Objective: Few studies of prescription stimulant non-oral, non-medical use (NMU) (defined by use not as prescribed) have been conducted in adults beyond the college population. The purpose of this study was to characterize prescription stimulant non-oral use, specifically intranasal (IN) use (snorting) in young adults. Method: Amazon’s MTurk platform was used to recruit participants for an online survey. Data were collected from March to April 2020. Results: Thirty-two percent (n = 157) of survey respondents (N = 975), aged 18 to 30, reported IN prescription stimulant use (average of 32.1 episodes of lifetime IN use). Adderall was the most-reported prescription stimulant used intranasally (89.2%). Most IN users (82%; n = 68) reported spending no more than 5 minutes tampering with prescription stimulants. Intranasal users said they would take the medication orally if unable to tamper or manipulate medication for IN use. Conclusion: These data help quantify a complex public health issue of ongoing IN use of prescription stimulants and suggest a potential role for manipulation-deterrent medications.
KW - ADHD
KW - intranasal use
KW - non-medical use
KW - prescription stimulants
UR - http://www.scopus.com/inward/record.url?scp=85135187543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135187543&partnerID=8YFLogxK
U2 - 10.1177/10870547221112948
DO - 10.1177/10870547221112948
M3 - Article
C2 - 35904240
AN - SCOPUS:85135187543
SN - 1087-0547
VL - 27
SP - 14
EP - 25
JO - Journal of Attention Disorders
JF - Journal of Attention Disorders
IS - 1
ER -
